Log in

Microvascular Function in Aging Among Women Living with HIV

  • Behavioral-Bio-Medical Interface (JL Brown and RJ DiClemente, Section Editors)
  • Published:
Current HIV/AIDS Reports Aims and scope Submit manuscript

Abstract

Combined antiretroviral therapy (CART) has turned HIV-infection to a treatable chronic disease during which many patients survive to middle and older age. However, they prematurely develop non-AIDS comorbidities such as cardiovascular disease, metabolic syndrome, diabetes, and HIV-associated neurocognitive disorders (HAND). Microcirculatory changes and endothelial dysfunction occur early both in HIV-infected and in aging patients, in whom they usually precede cardiovascular and neurocognitive impairments. Also, mild cognitive involvement has been reported in women during the menopausal transition. Disruption of the blood-brain barrier, as well as microvascular and cerebral blood flow changes, has been reported in HIV patients with HAND, including postmenopausal women. However, most studies addressing this issue included women aged less than 50 years. Whether HIV-infected women growing older with CART would be subsequently exposed to an increased progression of cognitive impairment overtime remains unknown.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. van Sighem AI, Gras JA, Reiss P, Brinkman K, de Wolf F. Life-expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS. 2010;24:1527–35.

    Article  PubMed  Google Scholar 

  2. Monsuez JJ, Charniot JC, Escaut L, et al. HIV-associated vascular disease: structural and functional changes, clinical implications. Int J Cardiol. 2009;133(3):293–306.

    Article  PubMed  Google Scholar 

  3. Borges JP, Tibirica E, Soares PP, et al. Assessment of vascular function in HIV-infected patients. HIV Clin Trials. 2011;12(4):216–21.

    Article  Google Scholar 

  4. Nightingale S, Winsto A, Letendre S, et al. Controversies in HIV-associated neurocognitive disorders. Lancet Neurol. 2014;13(11):1139–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Palios J, Ikonomidis J, Lekakis J, et al. Microcirculatory vascular dysfunction in HIV-1 infected patients receiving highly active antiretroviral therapy. Microcirculation. 2010;4:303–10.

    Article  CAS  Google Scholar 

  6. Bladowska J, Knysz B, Zimny A, et al. Value of perfusion-weighted MR imaging in the assessment of early cerebral alterations in neurologically asymptomatic HIV-1 positive and HCV positive patients. PLoS ONE. 2014;9(7):e102214.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Kanapathipillai R, Hickey M, Giles M. Human immunodeficiency virus and menopause. Menopause. 2013;9:983–90.

    Article  Google Scholar 

  8. Miller SA, Santoro N, Lo Y, et al. Menopause symptoms in HIV-infected and drug-using women. Menopause. 2005;3:348–56.

    Article  Google Scholar 

  9. Alcaide ML, Parmigiani A, Pallikuth S, et al. Immune activation in HIV-infected aging women on antiretrovirals—implications for age-associated comorbidities: a cross-sectional pilot study. PLoS ONE. 2013;8(5):e53804.

    Article  CAS  Google Scholar 

  10. Rubin LH, Sundermann EE, Cook JA, et al. An investigation of menopausal stage and symptoms on cognition in HIV-infected women. Menopause. 2014;9:997–1006.

    Article  Google Scholar 

  11. Maki P, Rubin LH, Valcour V, Martin E, Crystal H, Young M, et al. Cognitive function in women with HIV. Neurology. 2015;84:231–40. The Women’s Interagency HIV Study is the largest cohort study of neuropsychological outcomes among HIV-infected women.The 1521 included women (1019 HIV-infected) completed a comprehensive neuropsychological test battery repeated during follow up and correlated to HIV status.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Monsuez JJ, Dufaux J, Vittecoq D, Vicaut E. Hemorheology in asymptomatic HIV-infected patients. Clin Hemorheol. 2000;23:59–66.

    CAS  Google Scholar 

  13. Athanassiou GA, Moutzouri AG, Gogos CA, Skoutelis AT. Red blood cell deformability in patients with immunodeficiency virus infection. Eur J Clin Microbiol Infect Dis. 2010;7:845–9.

    Article  Google Scholar 

  14. Monsuez JJ, Vittecoq D, Dufaux J, Vicaut E. Reduced reactive hyperemia in HIV-infected patients. JAIDS. 2000;24:434–42.

    Google Scholar 

  15. Maggi P, Bellacosa C, Grattagliano V, Pastore G, Lapadula G. Functional impairments of microcirculation in HIV-positive patients: a laser Doppler fluxometry-based investigation. HIV Clin Trials. 2008;6:428–33.

    Article  Google Scholar 

  16. Wang D, Melancon JK, Verbesey J, et al. Microvascular endothelial dysfunction and enhanced thromboxane and endothelial contractility in patients with HIV. J AIDS Clin Res. 2014;4:267. doi:10.4172/2155-6113.1000267.

    Google Scholar 

  17. Van Wijk JP, de Koning EJ, Cabezas MC, et al. Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients. J Am Coll Cardiol. 2006;47:1117–23.

    Article  CAS  PubMed  Google Scholar 

  18. Torriani FJ, Komarow L, Parker RA, et al. Endothelial dysfunction in human immunodeficiency virus-infected antiretroviral naive subjects before and after starting potent antiretroviral therapy. J Am Coll Cardiol. 2008;52:569–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Sharma B. Oxidative stress in HIV patients receiving antiretroviral therapy. Curr HIV Res. 2014;12(1):13–21.

    Article  CAS  PubMed  Google Scholar 

  20. Kraft-Terry S, Gerena Y, Wojna V, et al. proteomic analyses of monocytes obtained from Hispanic women with HIV-associated dementia show depressed antioxidants. Proteomics Clin Appl. 2010;8:706–14.

    Article  Google Scholar 

  21. Bentov I, Reed MJ. The effect of aging on the cutaneous microvasculature. Microvasc Res. 2015;100:25–31.

    Article  PubMed  PubMed Central  Google Scholar 

  22. LeBlanc AJ, Hoying JB. Adaptation of the coronary microcirculation in aging. Microcirculation. 2016;2:157–67.

    Article  Google Scholar 

  23. Brown WR, Thore CR. Cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol. 2011;37:56–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Muller-Delp JM, Gurovich AN, Christou DD, Leeuwenburgh C. Redox balance in the aging microcirculation: new friends, new foes, and new clinical directions. Microcirculation. 2012;1:19–26.

    Article  CAS  Google Scholar 

  25. Fujii N, Meade RD, Alexander LM, et al. iNOS-dependent sweating and eNOS-dependent cutaneous vasodilation are evident in younger adults, but are diminished in older adults exercising in the heat. J Appl Physiol. 2016;120(3):318–27.

    Article  PubMed  Google Scholar 

  26. Ogrin R, Darzins P, Khalil Z. Age-related changes in microvascular blood flow and transcutaneous oxygen tension under basal and stimulated conditions. J Gerontol A Biol Sci Med Sci. 2005;60(2):200–6.

    Article  PubMed  Google Scholar 

  27. Chantier PD, Shrader CD, Tabone LF, et al. Cerebral cortical microvascular rarefaction in metabolic syndrome is dependent on insulin resistance and loss of nitric oxide bioavailability. Microcirculation. 2015;6:435–45.

    Article  CAS  Google Scholar 

  28. Walther G, Obert P, Dutheil F, et al. Metabolic syndrome individuals with and without type 2 diabetes mellitus present generalized vascular dysfunction: cross sectional study. Arterioscler Thromb Vasc Biol. 2015;35:1022–9.

    Article  CAS  PubMed  Google Scholar 

  29. Nix LM, Tien PC. Metabolic syndrome, diabetes, and cardiovascular risk in HIV. Curr HIV/AIDS Rep. 2014;11:275–8.

    Article  Google Scholar 

  30. Gerena Y, Skolasky RL, Velez JM, et al. Soluble and cell-associated insulin receptor dysfunction correlates with severity of HAND in HIV-infected women. PLoS ONE. 2012;7(5):e37358. This article shows the relationship between HIV-induced metabolic syndrome, insulin resistance, and HIV-associated cognitive impairment. Evidence is shown that: 1 insulin receptor secretion is increased in HIV-infected women; 2 increased insulin receptor secretion is associated with cognitive impairment in these women.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Wu DT, Woodman SE, Weiss JM, et al. Mechanisms of leukocyte trafficking into the CNS. J Neurovirol. 2000;6:582–5.

    Google Scholar 

  32. Takahashi K, Wessellingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD. Localization of HIV-1 in human brain using polymerase chain reaction in situ hybridization and immunocytochemistry. Ann Neurol. 1996;39:705–11.

    Article  CAS  PubMed  Google Scholar 

  33. Strazza M, Pirrone V, Wigahl B, Nonemacher MR. Breaking down the barrier: the effect of HIV-1 on the blood-brain barrier. Brain Res. 2011;1399:96–115.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Xu R, Feng X, **e X, Zhang J, Wu D, Xu L, et al. HIV-1 Tat protein increases the permeability of brain endothelial cells by both inhibiting occluding expression and cleaving occluding via matrix metalloproteinase-9. Brain Res. 2012;1436:13–9.

    Article  CAS  PubMed  Google Scholar 

  35. Toborek M, Lee YW, Pu H, et al. HIV-Tat protein induces oxidative and inflammatory pathways in brain circulation. J Neurochem. 2003;84:109–79.

    Google Scholar 

  36. Towgood KJ, Pikanen M, Kulasegaram R, et al. regional cerebral blood flow and FDG uptake to asymptomatic HIV-1 men. Human Brain Mapp. 2013;34:2484–93.

    Article  Google Scholar 

  37. Ances BM, Valda F, Cherner M, et al. HIV and chronic metamphetamine dependence affect cerebral blood flow. J Neuroimmune Pharmacol. 2011;6:409–19.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Ances BM, Valda F, Yeh MJ, et al. HIV infection and aging independently affect brain function as measured by functional resonance imaging. J Infect Dis. 2010;201:336–40.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Silva JN, Polesskaia O, Wei HS, et al. Chronic central nervous system expression of HIV-1 Tat leads to accelerated rarefaction of neocortical capillaries and loss of red blood cell velocity heterogeneity. Microcirculation. 2014;7:664–76. In this animal study, the authors show that HIV-1 protein Tat accelerates cerebral microvascular rarefaction and reduces cerebral microvascular blood flow.

    Article  CAS  Google Scholar 

  40. Airaldi M, Bandera A, Trabattoni D, et al. Neurocognitive impairment in HIV-infected naïve patients with advanced disease: the role of virus and intrathecal immune activation. Clin Dev Immunol. 2012. doi:10.1155/2012/467154.

    Google Scholar 

  41. Elbirt D, Mahlab-Guri K, Bezalel-Rosenberg S, Gill H, Attali M, Asher I. HIV-associated neurocognitive disorders (HAND). IMAJ. 2015;17:54–9.

    PubMed  Google Scholar 

  42. Lindl KA, Marks DR, Kolson DL, Jordan-Schiutto KL. HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities. J Neuroimmune Pharmacol. 2010;5:294–309.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Gustafson DR, Mielke MM, Tien PC, et al. Anthropometric measures and cognition in middle-aged HIV-infected and uninfected women. The Women’s Interagency HIV study. J Neurovirol. 2013;6:574–85.

    Article  Google Scholar 

  44. Valcour V, Maki P, Bacchetti P, et al. Insulin resistance and cognition among HIV-infected and HIV-uninfected adult women: the Women’s Interagency HIV study. AIDS Res Human Retrovir. 2012;28(5):447–53.

    Google Scholar 

  45. Gerena Y, Menendez-Delmestre R, Skolasky RL, et al. Soluble insulin receptor as a source of insulin resistance and cognitive impairment in HIV-seropositive women. J Neurovirol. 2015;2:113–9.

    Article  CAS  Google Scholar 

  46. Cysique LA, Moffat K, Moore DM, et al. HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a H MRS study. PLoS ONE. 2013;8:e61738.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Guaraldi G, Zona S, Alexopoulos N, et al. Coronary aging in HIV-infected patients. Clin Infect Dis. 2009;49:1756–62.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean-Jacques Monsuez.

Ethics declarations

Conflict of Interest

Olivier Bouchaud reports grants from GSK, MSD, Gilead, and ANRS; personal fees from BMS, MSD; non-financial support from Gilead and MSD.

Jean-Jacques Monsuez and Catherine Belin declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Behavioral-Bio-Medical Interface

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Monsuez, JJ., Belin, C. & Bouchaud, O. Microvascular Function in Aging Among Women Living with HIV. Curr HIV/AIDS Rep 13, 392–398 (2016). https://doi.org/10.1007/s11904-016-0339-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11904-016-0339-3

Keywords

Navigation